{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:47:50Z","timestamp":1790732870904,"version":"4.1.0"},"reference-count":72,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bilirubin is a heme catabolite and Ugt1a1 is the only enzyme involved in the biological elimination of bilirubin. Partially functional or non-functional Ugt1a1 may result in neuronal damage and death due to the accumulation of unconjugated bilirubin in the brain. The understanding of the role of alternative bilirubin detoxification mechanisms that can reduce bilirubin toxicity risk is crucial for developing novel therapeutic strategies. To provide a proof-of-principle showing whether activation of alternative detoxification pathways could lead to life-compatible bilirubin levels in the absence of Ugt1a1 activity, we used Ugt1\u2212\/\u2212 hyperbilirubinemic mice devoid of bilirubin glucuronidation activity. We treated adult Ugt1\u2212\/\u2212 mice with TCPOBOP, a strong agonist of the constitutive androstane receptor (CAR). TCPOBOP treatment decreased plasma and liver tissue bilirubin levels by about 38%, and resulted in the transcriptional activation of a vast array of genes involved in bilirubin transport and metabolism. However, brain bilirubin level was unaltered. We observed ~40% degradation of bilirubin in the liver microsomes from TCPOBOP treated Ugt1\u2212\/\u2212 mice. Our findings suggest that, in the absence of Ugt1a1, the activation of alternative bilirubin clearance pathways can partially improve hyperbilirubinemic conditions. This therapeutic approach may only be considered in a combinatorial manner along with other treatments.<\/jats:p>","DOI":"10.3390\/ijms231810703","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T23:16:36Z","timestamp":1663197396000},"page":"10703","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Activation of Alternative Bilirubin Clearance Pathways Partially Reduces Hyperbilirubinemia in a Mouse Model Lacking Functional Ugt1a1 Activity"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2231-7263","authenticated-orcid":false,"given":"Bhaswati","family":"Banerjee","sequence":"first","affiliation":[{"name":"Mouse Molecular Genetics Group, ICGEB, Padriciano, 99, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-2837","authenticated-orcid":false,"given":"Olayemi Joseph","family":"Olajide","sequence":"additional","affiliation":[{"name":"Mouse Molecular Genetics Group, ICGEB, Padriciano, 99, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bortolussi","sequence":"additional","affiliation":[{"name":"Mouse Molecular Genetics Group, ICGEB, Padriciano, 99, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9628-0494","authenticated-orcid":false,"given":"Andr\u00e9s F.","family":"Muro","sequence":"additional","affiliation":[{"name":"Mouse Molecular Genetics Group, ICGEB, Padriciano, 99, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/HYPERTENSIONAHA.118.11130","article-title":"Bilirubin, a Cardiometabolic Signaling Molecule","volume":"72","author":"Hinds","year":"2018","journal-title":"Hypertension"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jpba.2018.09.034","article-title":"Development of new methods for determination of bilirubin","volume":"162","author":"Ngashangva","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/21678707.2018.1495558","article-title":"Advances in understanding disease mechanisms and potential treatments for Crigler\u2013Najjar syndrome","volume":"6","author":"Bortolussi","year":"2018","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_4","unstructured":"Kalakonda, A., Jenkins, B.A., and John, S. (2022). Physiology, Bilirubin. StatPearls\u00a9 2022, StatPearls Publishing LLC."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","article-title":"Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man","volume":"269","author":"Bosma","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3389\/fphar.2017.00887","article-title":"Membrane Transporters for Bilirubin and Its Conjugates: A Systematic Review","volume":"8","author":"Passamonti","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/dmd.113.055772","article-title":"The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia","volume":"42","author":"Keppler","year":"2014","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-8278(02)00359-8","article-title":"Inherited disorders of bilirubin metabolism","volume":"38","author":"Bosma","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1136\/gut.52.12.1668","article-title":"Bilirubin, a curse and a boon","volume":"52","author":"Ostrow","year":"2003","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Petrova, A., Mehta, R., Birchwood, G., Ostfeld, B., and Hegyi, T. (2006). Management of neonatal hyperbilirubinemia: Pediatricians\u2019 practices and educational needs. BMC Pediatr., 6.","DOI":"10.1186\/1471-2431-6-6"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1385\/NMM:8:4:513","article-title":"Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns","volume":"8","author":"Watchko","year":"2006","journal-title":"Neuromolecular Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0009922811398964","article-title":"Screening and Follow-Up for Neonatal Hyperbilirubinemia: A Review","volume":"51","author":"Burgos","year":"2012","journal-title":"Clin. Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"114","author":"Hyperbilirubinemia","year":"2004","journal-title":"Pediatrics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.taap.2012.03.010","article-title":"Metabolism of bilirubin by human cytochrome P450 2A6","volume":"261","author":"Arthur","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1515\/bc.2010.065","article-title":"Contributions of the Ah receptor to bilirubin homeostasis and its antioxidative and atheroprotective functions","volume":"391","author":"Bock","year":"2010","journal-title":"Biol. Chem."},{"key":"ref_16","first-page":"722","article-title":"Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat","volume":"43","author":"Kapitulnik","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1073\/pnas.75.2.682","article-title":"Stimulation of bilirubin catabolism in jaundiced Gunn rats by an induced of microsomal mixed-function monooxygenases","volume":"75","author":"Kapitulnik","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(80)80802-7","article-title":"An alternate pathway for bilirubin catabolism","volume":"111","author":"Kaul","year":"1980","journal-title":"FEBS Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/hep.29599","article-title":"Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia","volume":"67","author":"Fujiwara","year":"2018","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1067\/S0022-3476(03)00298-1","article-title":"Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats","volume":"143","author":"Nishioka","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI200418385","article-title":"A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR","volume":"113","author":"Huang","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/hep.20570","article-title":"Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice","volume":"41","author":"Saini","year":"2005","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.3892\/mmr.2017.6435","article-title":"Constitutive androstane receptor activation promotes bilirubin clearance in a murine model of alcoholic liver disease","volume":"15","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1038\/s41598-021-90687-5","article-title":"Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia","volume":"11","author":"Verkade","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep4.1082","article-title":"Severe Neonatal Hyperbilirubinemia in Crigler-Najjar Syndrome Model Mice Can Be Reversed With Zinc Protoporphyrin","volume":"1","author":"Fujiwara","year":"2017","journal-title":"Hepatol. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.0630614100","article-title":"Induction of bilirubin clearance by the constitutive androstane receptor (CAR)","volume":"100","author":"Huang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.20784","article-title":"CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice","volume":"42","author":"Wagner","year":"2005","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"46489","DOI":"10.1038\/srep46489","article-title":"Isothiocyanates induce UGT1A1 in humanized UGT1 mice in a CAR dependent fashion that is highly dependent upon oxidative stress","volume":"7","author":"Yoda","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_29","first-page":"1057","article-title":"Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity in vivo in mice","volume":"7","author":"Bortolussi","year":"2014","journal-title":"Dis. Models Mech."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1096\/fj.11-195461","article-title":"Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer","volume":"26","author":"Bortolussi","year":"2012","journal-title":"FASEB J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.21236","article-title":"Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins","volume":"44","author":"Huang","year":"2006","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.taap.2011.08.011","article-title":"Inducible bilirubin oxidase: A novel function for the mouse cytochrome P450 2A5","volume":"257","author":"Arthur","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.taap.2013.04.013","article-title":"Cytochrome P450 2A5 and bilirubin: Mechanisms of gene regulation and cytoprotection","volume":"270","author":"Kim","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/138920011795016845","article-title":"CYP2A5 induction and hepatocellular stress: An adaptive response to perturbations of heme homeostasis","volume":"12","author":"Kirby","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1016\/j.febslet.2007.11.011","article-title":"PPARalpha-dependent induction of the energy homeostasis-regulating nuclear receptor NR1i3 (CAR) in rat hepatocytes: Potential role in starvation adaptation","volume":"581","author":"Wieneke","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/oby.20559","article-title":"Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21","volume":"22","author":"Hinds","year":"2014","journal-title":"Obesity"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Stec, D.E., John, K., Trabbic, C.J., Luniwal, A., Hankins, M.W., Baum, J., and Hinds, T.D. (2016). Bilirubin Binding to PPAR\u03b1 Inhibits Lipid Accumulation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153427"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2174\/138161209789058219","article-title":"Pharmacological therapies for unconjugated hyperbilirubinemia","volume":"15","author":"Cuperus","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1007\/PL00014330","article-title":"Diagnosis and management of Crigler-Najjar syndrome","volume":"158","author":"Jansen","year":"1999","journal-title":"Eur. J. Pediatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"ra31","DOI":"10.1126\/scisignal.2003705","article-title":"Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling","volume":"6","author":"Mutoh","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1046\/j.1432-1327.2000.01812.x","article-title":"Oxidative degradation of bilirubin produces vasoactive compounds","volume":"267","author":"Kranc","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fphar.2011.00082","article-title":"Regulation of bilirubin clearance by ligand-activated transcription factors of the endo- and xenobiotic metabolism system","volume":"2","author":"Bock","year":"2011","journal-title":"Front. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1124\/dmd.117.075135","article-title":"RNA Sequencing Reveals Age and Species Differences of Constitutive Androstane Receptor-Targeted Drug-Processing Genes in the Liver","volume":"45","author":"Cheng","year":"2017","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/hep.30109","article-title":"TCPOBOP-Induced Hepatomegaly and Hepatocyte Proliferation are Attenuated by Combined Disruption of MET and EGFR Signaling","volume":"69","author":"Bhushan","year":"2019","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1194\/jlr.M800226-JLR200","article-title":"The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress","volume":"50","author":"Maglich","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/07853890310008224","article-title":"Drug-activated nuclear receptors CAR and PXR","volume":"35","author":"Honkakoski","year":"2003","journal-title":"Ann. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/26996","article-title":"Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta","volume":"395","author":"Forman","year":"1998","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1389200054633899","article-title":"CAR, the continuously advancing receptor, in drug metabolism and disease","volume":"6","author":"Qatanani","year":"2005","journal-title":"Curr. Drug Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.3389\/fphar.2021.730416","article-title":"Regulation of Cytochrome P450 2a5 by Artemisia capillaris and 6,7-Dimethylesculetin in Mouse Hepatocytes","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M109.048108","article-title":"Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3)","volume":"284","author":"Mutoh","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1128\/MCB.19.9.6318","article-title":"Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene","volume":"19","author":"Kawamoto","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/jhep.2001.24172","article-title":"The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR","volume":"33","author":"Sugatani","year":"2001","journal-title":"Hepatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJM196612292752602","article-title":"Enhancement of Glucuronide-Conjugating Capacity in a Hyperbilirubinemic Infant Due to Apparent Enzyme Induction by Phenobarbital","volume":"275","author":"Yaffe","year":"1966","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/MCB.20.9.2951-2958.2000","article-title":"The Xenobiotic Compound 1,4-Bis[2-(3,5-Dichloropyridyloxy)]Benzene Is an Agonist Ligand for the Nuclear Receptor CAR","volume":"20","author":"Tzameli","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease","volume":"71","author":"Borst","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/dmd.30.8.918","article-title":"Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1\/2 by phenobarbital","volume":"30","author":"Xiong","year":"2002","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"ref_57","first-page":"145","article-title":"Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-\/- lethal mouse model of neonatal hyperbilirubinemia","volume":"26","author":"Bockor","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_59","first-page":"5196","article-title":"Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray","volume":"62","author":"Thimmulappa","year":"2002","journal-title":"Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1074\/jbc.M309660200","article-title":"Regulation of Heme Oxygenase-1 Expression through the Phosphatidylinositol 3-Kinase\/Akt Pathway and the Nrf2 Transcription Factor in Response to the Antioxidant Phytochemical Carnosol","volume":"279","author":"Martin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0076-6879(05)00006-6","article-title":"Regulation of the human UGT1A1 gene by nuclear receptors constitutive active\/androstane receptor, pregnane X receptor, and glucocorticoid receptor","volume":"400","author":"Sugatani","year":"2005","journal-title":"Methods Enzymol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1074\/jbc.M610790200","article-title":"Nrf2-Keap1 Signaling Pathway Regulates Human UGT1A1 Expression in Vitro and in Transgenic UGT1 Mice","volume":"282","author":"Yueh","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1600-0773.2001.088001003.x","article-title":"Neonatal Hepatic Drug Elimination","volume":"88","author":"Gow","year":"2001","journal-title":"Pharmacol. Toxicol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1389450118666170125144557","article-title":"Cytochrome P450 Structure, Function and Clinical Significance: A Review","volume":"19","author":"Manikandan","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"ref_65","first-page":"1","article-title":"Brain Cytochrome p450 enzymes: A possible Therapeutic Targets for Neurological Diseases","volume":"2","author":"Sabrina","year":"2015","journal-title":"Ther. Targets Neurol. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Raghunath, A., Sundarraj, K., Arfuso, F., Sethi, G., and Perumal, E. (2018). Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance. Cancers, 10.","DOI":"10.3390\/cancers10120481"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1158\/0008-5472.CAN-04-1459","article-title":"The orphan nuclear receptor constitutive active\/androstane receptor is essential for liver tumor promotion by phenobarbital in mice","volume":"64","author":"Yamamoto","year":"2004","journal-title":"Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Dimauro, I., Pearson, T., Caporossi, D., and Jackson, M.J. (2012). A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue. BMC Res. Notes, 5.","DOI":"10.1186\/1756-0500-5-513"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.cell.2013.05.038","article-title":"A bilirubin-inducible fluorescent protein from eel muscle","volume":"153","author":"Kumagai","year":"2013","journal-title":"Cell"},{"key":"ref_70","first-page":"35","article-title":"A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity","volume":"5","author":"Adeosun","year":"2018","journal-title":"React. Oxyg. Species (Apex)"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0003-2697(78)90245-2","article-title":"A simple and sensitive assay of 7-ethoxycoumarin deethylation","volume":"85","author":"Aitio","year":"1978","journal-title":"Anal. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Gabbia, D., Pozzo, L., Zigiotto, G., Roverso, M., Sacchi, D., Dalla Pozza, A., Carrara, M., Bogialli, S., Floreani, A., and Guido, M. (2018). Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204336"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/18\/10703\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:31:11Z","timestamp":1760142671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/18\/10703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":72,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ijms231810703"],"URL":"https:\/\/doi.org\/10.3390\/ijms231810703","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]}}}